IMR-1 is primarily used in research settings as a specific inhibitor of the c-MYC oncogene pathway. It has shown potential in studies targeting cancer cells, particularly in inhibiting the proliferation of cells that rely on c-MYC for growth and survival. Researchers utilize IMR-1 to explore its effects on tumor suppression and to study the mechanisms of c-MYC-driven cancers. Its application in preclinical studies helps in understanding the molecular pathways involved in cancer progression and in developing potential therapeutic strategies. Additionally, IMR-1 is employed in biochemical assays to investigate protein-protein interactions and signaling pathways associated with c-MYC activity.